About 10% of the genome of Mycobacterium tuberculosis codes for the PE and PPE families of proteins (7) , which are glycine rich and are exclusive to M. tuberculosis. The 69 members of the PPE protein family have a conserved N-terminal domain that comprises ϳ180 amino acids followed by C-terminal segments that vary markedly in sequence and length. These proteins fall into three groups, one of which constitutes the MPTR class characterized by the presence of multiple tandem copies of the motif Asn-X-Gly-X-Gly-Asn-X-Gly. The second subgroup contains a characteristic well-conserved motif, Gly-X-X-Ser-Val-Pro-X-X-Trp, around position 350. The proteins in the third group are unrelated except for the presence of the common PPE domain. The subcellular locations of a few PPE proteins are known (6, 25) , and in only one case (7) , that of a lipase (Rv3097), has a function been suggested. There are few studies supporting the notion that PE and PPE proteins could be of functional importance (7, 23) . It is widely speculated that they could be responsible for generating antigenic variation (1, 4, 6, 8, 12, 27) . However, the effects the PPE family proteins, unique in their protein sequences and possible structure, may have on the immune system have not been well documented. Furthermore, a qualitative and quantitative immune response to PPE proteins in a clinical setting has not been shown. Since 180 amino acid residues in the N-terminal regions of PPE proteins are conserved, it is interesting to speculate that the variation in sequence and length in the C-terminal region could represent a source of antigenic variability.
Based on in silico analysis and DNA microarray expression data (24), we selected an ORF, Rv2430c, whose product displays a high antigenic index and evaluated its importance in eliciting immune responses in a panel of human sera obtained from three well-classified categories of patients: (i) those reporting TB for the first time, (ii) those presenting with a relapse of TB, and (iii) those with extrapulmonary cases. Clinically healthy human sera were used as controls to compare the immunological responses to the protein. Enzyme-linked immunosorbent assay (ELISA) using the recombinant protein showed good specificity and sensitivity, suggesting that the product of this PPE family ORF, Rv2430c, induces a strong B-cell response in infected subjects.
MATERIALS AND METHODS
In silico analysis of Rv2430c. In silico pattern search analysis of the PPE family was carried out to classify the products of the various ORFs into three subgroups. Products of ORFs with Յ200 amino acids and belonging to the third subgroup of the PPE family were further analyzed using protein analysis software (Protean version 4.0, Lasergene Navigator; DNASTAR Inc., Madison, Wis.) to calculate their antigenic indexes.
RNA extraction and reverse transcriptase (RT) PCR. RNA was extracted from 10 9 H 37 Rv cells, cultured in vitro in Middlebrook 7H9 medium supplemented with albumin-dextrose complex according to the Qiaquick total RNA extraction kit (Qiagen Inc.) instructions, dissolved in 50 l of nuclease-free water, and stored at Ϫ70°C until further use. First-strand synthesis was carried out using avian myeloblastosis virus reverse transcriptase. This was followed by heat denaturation to inactivate the enzyme. Subsequent second-strand synthesis was performed using Tfl polymerase. The PCR product was visualized by electrophoresis in a 1% agarose gel.
Expression and purification of the recombinant protein encoded by Rv2430c. Genomic DNA of H37Rv was extracted using the Genome Extraction kit provided by Epicentre Technologies, as described earlier (26) . The Rv2430c gene was PCR amplified from the genomic DNA of H 37 Rv using upstream (5Ј-GGA TCCATGCATTTCGAAGCGTAC-3Ј) and downstream (5Ј-AAGCTTCTAAG TGTCTGTACGCGATGA-3Ј) primers. BamHI and HindIII sites were incorporated in the 5Ј and 3Ј ends of the primers, respectively. The purified fragment was ligated into the pGEMT-Easy vector (Promega Inc.), and the recombinant clone carrying the Rv2430c insert was confirmed by DNA sequencing (ABI Prism 377 DNA Sequencer; PE Biosystems). The insert was then subcloned as a BamHI and HindIII fragment into the PQE30 expression vector (Qiagen Inc.) to generate the plasmid construct PQERv2430c carrying Rv2430c as an N-terminal histidine-tagged fusion. PQERv2430c was transformed into the host M15pREP4 strain of Escherichia coli. A single colony of E. coli strain M15pREP4 harboring PQERv2430c was inoculated into 5 ml of Luria-Bertani broth with the appropriate antibiotics (100 g of ampicillin/ml and 25 g of kanamycin/ml) and grown overnight at 37°C with constant agitation; 100 l of this overnight culture was inoculated into 5 ml of Luria-Bertani broth with the appropriate antibiotics and grown to an optical density at 590 nm of 0.6, at which time expression was induced with 1 mM IPTG. A separate aliquot of uninduced culture was kept as a control. Cells were harvested 3 h postinduction, suspended in 1ϫ SDS sample buffer, and denatured by being heated at 100°C for 10 min. The recombinant Study population. Serum samples were obtained from 92 TB patients who had reported to the Mahavir Hospital and Research Centre, Hyderabad, India, and 10 clinically healthy donors. The 92 patients belonged to three well-defined categories. Category 1 (n ϭ 32) comprised patients who had contracted the pathogen for the first time and had no history of TB treatment. Category 2 (n ϭ 30) comprised patients with relapsed TB, i.e., who were treated earlier for TB but the symptoms resurfaced after completion of the treatment. Category 3 (n ϭ 30) comprised patients with extrapulmonary TB in which the disease was confirmed by tissue biopsy. In the cases of category 1 and category 2 patients, diagnosis was confirmed by examination of the sputum (acid-fast bacillus smear positive). Clinically healthy donors were vaccinated with Mycobacterium bovis BCG. The study was carried out after approval from the Institute Bioethics Committee.
Statistical analysis. Student's t test was used for analysis of statistical significance (P value). Graphpad Quickcalcs (online t test calculator [http://www .graphpad.com/quickcalcs/ttest1.cfm]) was used for this purpose.
RESULTS
The product of the hypothetical PPE ORF Rv2430c has a high antigenicity profile score and is expressed at the mRNA level. In silico analyses of the PPE ORF products, Յ200 amino acids in length, belonging to subgroup 3 of the PPE family (7) were carried out. Rv2430c and Rv3425 displayed major antigenic stretches ( Fig. 1) with peak values of Ն3.0. However, an analysis of the microarray expression data (24) identified Rv2430c as one of the overexpressed genes in an IdeR mutant of M. tuberculosis, and it was thereby implicated in pathogenesis. Rv2430c was thus selected for our study. Rv2430c was further subjected to detailed analysis to predict its likely structure through various algorithms. The Predict Protein server (http://www.embl-heidelberg.de/predictprotein/) gave a very low score for Rv2430c, pointing to the unlikely possibility that this ORF encoded a transmembrane protein (data not shown).
To check whether the hypothetical Rv2430c indeed represented a functional gene, the mRNA extracted from in vitrocultured H 37 Rv cells was used as a template for reverse transcription followed by PCR. The RT-PCR product was fractionated on a 1% agarose gel. A 597-bp band was observed upon staining with ethidium bromide, indicating that the ORF was expressed at the mRNA level in the liquid cultures of M. tuberculosis ( Fig. 2A) . The ORF Rv2430c was expressed as a His-tagged fusion protein in E. coli (Fig. 2B) and used for immunological studies.
The recombinant PPE protein Rv2430c displays strong Bcell responses during infection with TB. Having shown that the ORF encoding RV2430c of M. tuberculosis was expressed at the mRNA level, experiments were designed to evaluate the immune response of TB patients to recombinant Rv2430c PPE protein. For this, the recombinant Rv2430c protein was used to screen the TB patient sera by ELISA, using anti-human IgG-HRP and anti-human IgM-HRP as conjugates. The humoral immune responses directed against the recombinant protein by patients with TB and healthy controls were compared. The data (Fig. 3) reveal that the sera of all the infected patients mounted significantly higher antibody responses against Rv2430c than those of the healthy controls (P Ͻ 0.0001). Since negligible antibody responses were obtained in the healthycontrol group (Fig. 3) , it is likely that this protein is expressed during the course of M. tuberculosis infection, and it may be associated with disease manifestation and progression.
Immunodominant nature of Rv2430c. Since all the patients infected with TB revealed strong humoral responses against Rv2430c compared to the healthy controls, it was of interest to compare the antibody responses in various clinical categories and also to evaluate whether Rv2430c is immunodominant. For this, we chose recombinant Hsp10 of M. tuberculosis, which is a well-known immunodominant antigen of M. tuberculosis (28) . Figure 4 clearly shows that strong antibody responses were elicited against Rv2430c in all three study groups (category 1, category 2, and category 3). Rv2430c elicited statisti- (Fig. 4A) . Patients belonging to categories 2 and 3 exhibited Rv2430c-specific antibody equivalent to that for Hsp10 ( Fig. 4B and C) . Since the PPD antigen of M. tuberculosis is also used to diagnose TB infection (2, 15, 29) , we compared the immunopotentiality of Rv2430c over PPD only in cases of fresh infection (Fig. 4A) . The results clearly indicated that the PPE protein Rv2430c is far more immunogenic and could elicit a stronger B-cell response than PPD. Sera from the fresh-infection category responded better against the Rv2430c antigen than against PPD (P Ͻ 0.0001) (Fig. 4A) . In order to compare the serological sensitivities of Rv2430c and Hsp10, the data presented in Fig. 4 were recalculated as percentages of individuals showing absorbances above 0.65 at 492 nm. Although only 28.12% of individuals with fresh infections mounted strong antibody responses of the IgG type to Hsp10, a very high percentage of individuals (62.5%) recognized Rv2430c (Fig. 5A) . Similar conclusions could be drawn when IgM antibodies were assayed (Rv2430c versus Hsp10, 71 versus 37.5%) (Fig. 5B) . From these results, it is apparent that Rv2430c shows better reactivity vis-a-vis Hsp10 to sera from patients with fresh infection than to those of relapsed or extrapulmonary-TB patients. Our results, therefore, convincingly demonstrate the immunodominant nature of the product of the hypothetical PPE ORF Rv2430c. 
DISCUSSION
The 69 members of the PPE protein family have a conserved N-terminal domain that comprises ϳ180 amino acids followed by C-terminal segments that vary markedly in sequence and length (7) . Based on our pattern search analysis of the TubercuList database (http://genolist.pasteur.fr/TubercuList/), these proteins were categorized into three groups. Subgroup 1, represented by 20 members, constitutes the MPTR class characterized by the presence of multiple tandem copies of the motif Asn-X-Gly-X-Gly-Asn-X-Gly. The second subgroup, comprising 21 members, contains a characteristic well-conserved motif, Gly-X-X-Ser-Val-Pro-X-XTrp, around position 350. The proteins of the third subgroup, with 28 members, are unrelated except for the presence of the common PPE domain. That ORF products across the subgroup do not react immunologically was evident from our studies with Rv2608 (unpublished data). Rv2430c belongs to the third subgroup. ORFs belonging to the third subgroup with coding capacities of Յ200 amino acids were shortlisted. This shortlist was further narrowed down based on two very important criteria, namely, the antigenic profile and the association of the ORF with pathological conditions as evident from DNA microarray expression data (24) . Rv2430c and Rv3425 were the ORFs with the highest antigenicity indexes. DNA microarray results demonstrated that of these two ORFs, Rv2430c was one of the genes induced in an IdeR mutant of M. tuberculosis (24) , pointing to its possible role in pathogenesis. Rv2430c was accordingly shortlisted and evaluated for the role of its product as an antigen in a clinical setting.
The ORF was shown to be RT-PCR positive, pointing to the likelihood that it is expressed during infection. The Rv2430c ORF was expressed in E. coli, and the recombinant protein was purified and tested for its ability to recognize IgG antibody in the sera of TB patients and healthy individuals.
The TB patients used in our study represent a heterogeneous population, including fresh infection cases characterized by patients who contracted the pathogen for the first time (category 1); relapsed cases, in which the disease resurfaced after the completion of treatment (category 2); and extrapulmonary cases, which are mostly sputum negative (category 3). The immune response profiles of Rv2430c in different clinical categories were studied. The PPE protein Rv2430c was found to be recognized by antibodies in the sera of infected patients in ELISA with a serum dilution of 1:200, whereas poorer ELISA reactivity was observed for the sera of all of the healthy individuals. The presence of antibodies to Rv2430c in sera from TB patients (Fig. 3) and their absence in sera from healthy individuals suggests that the protein is expressed in vivo during active infection with M. tuberculosis and that the native molecule is immunogenic.
Several reports have emphasized the observation of a lack of sufficient immune responses in TB patients against many promising serodiagnostic antigens of M. tuberculosis. This fact is more distressing in cases of fresh infection, where in a majority of the cases the immune system is not sufficiently primed to elicit a strong antibody response against most of the M. tuberculosis antigens. The recombinant Rv2430c protein was very strongly recognized by all three categories of patients, including the fresh-infection group (category 1). The members of the heat shock protein family, including Hsp70 (20, 28) and Hsp10 (28) , have been known to elicit a strong B-cell response. Surprisingly, in our study, the immunodominant antigen Hsp10, though recognized by category 2 and 3 patient sera, was not sensitive enough to detect the patients with fresh infections (category 1). The picture remained unaltered when we used PPD in place of Hsp10. It is pertinent to note that although several antigens have been tested for use in serodiagnosis, no test with a single antigen has proved able to achieve sensitivity and specificity in a study population that is suitably large and heterogeneous (3, 5, 9, 11, 13, 14, 16, 17, 18, 19, 21, 22) . The factors responsible for this include (i) the stage of the disease, (ii) the location of the infection, and (iii) the genetic background. Our results show that the PPE protein Rv2430c, which lacks a transmembrane domain and is therefore likely to be cytosolic or secretory in localization, is an immunodominant B-cell target antigen with apparent diagnostic potential. It is also interesting to speculate on the use of Rv2430c, along with other immunodominant antigens (10), for vaccine development.
